Heart Failure POC & LOC Devices Market Research Report - Global Forecast till 2032

Heart Failure POC & LOC Devices Market Research Report Information By Test Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-based Systems), By End User (Hospitals & Clinics, Homecare, Specialty Centers, Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/HC/9169-HCR | 120 Pages | Author: Kinjoll Dey | March 2024         

Heart Failure POC and LOC Devices Market Speak to Analyst Request a Free Sample

Global Heart Failure POC & LOC Devices Market Overview


Heart Failure POC & LOC Devices Market Size was valued at USD 0.05 billion in 2022. The heart failure POC & LOC devices market industry is projected to grow from USD 0.0582 billion in 2023 to USD 0.1976 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 16.50% during the forecast period (2023 - 2032). The primary market drivers anticipated to drive the market include R&D towards developing innovative LOC-based assays for the detection of cardiovascular disease (CVD). 


Heart Failure POC & LOC Devices Market


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Heart Failure POC & LOC Devices Market Trends



  • Growing demand for POC & LOC devices is anticipated to fuel the market growth


Lab-on-chip (LOC) is used to accelerate disease diagnosis due to factors including simplicity of use, speed of results, and high throughput. POC helps identify cardiac indicators and time-critical elements so that medical problems can be handled more successfully. The need for POC and LOC devices is driven by worries about mobility and mortality due to cardiovascular disease. The number of POC tests aimed at different biomarkers has expanded, and various private and public sectors have increased their spending in creating cutting-edge POC and LOC devices, leading to increased market demand. Leading businesses are also anticipated to expand their spending on improved goods and incorporate smartphones, apps, and POC detection for controlling patient heart health in the upcoming years. For instance, the accuracy of HF diagnosis, severity estimate, and adverse event prediction has increased thanks to blood tests that measure biomarkers. The importance of biomarkers in managing HF is increased because they may be quickly assessed at the point of care. This has been made possible by creating mobile analytical devices, also called point-of-care testing (POCT) devices, which benefit from developments in microfluidics and nanotechnology. Increasing LOC device usage is anticipated to fuel market expansion over the forecast period.


The heart failure POC & LOC device market is anticipated to be largely driven by the rise in CVDs.POC devices assist in measuring particular cardiac indicators like troponin, but LOC technology can potentially improve disease diagnosis. Heart disease was the main cause of death worldwide in December 2020, accounting for around one-third of fatalities in 2019, and this trend is predicted to continue. In 2019, China had the most heart disease fatalities, followed by India, Russia, the US, and Indonesia. Additionally, according to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths). In order to improve the management of data for patients with CVD, several large companies are competing to release high-quality devices and accessories. The growing patient population has eventually increased the demand for POC and LOC devices, which will continue to drive the market's CAGR.


Furthermore, there is a need for substantial R&D to discover more effective treatments and diagnostic techniques to stop the rapid rise of CVD problems as the worldwide burden of CVD rises. Point-of-care testing (POCT), a crucial technology for diagnosing CVDs such as heart failure, will drive the market for heart failure POC & LOC devices in the future. This is due to the growth in R&D investments for heart and CVD. An investment of USD 190 million will be committed over the next ten years for heart disease-related research, according to a study released by the government of New South Wales in June 2018. Furthermore, NIH funding for cardiovascular diseases increased from USD 1,964 million in 2013 to an estimated USD 2,496 million in 2020. Therefore, such an increase in funding will eventually support the heart failure POC & LOC devices market revenue.


Heart Failure POC & LOC Devices Market Segment Insights


Heart Failure POC & LOC Devices Test Type Insights


The heart failure POC & LOC devices market segmentation, based on test type includes Proteomic Testing, Metabolomic Testing, and Genomic Testing. The proteomic testing segment dominated the market owing to the test type's high demand. A significant factor in the growth of this market is the widespread usage of POC devices for protein marker testing. However, due to the fact that most businesses have focused on this biomarker and regard it as a significant revenue-generating segment, it is anticipated that the metabolomic testing segment will grow quickly during the forecast period.


Heart Failure POC & LOC Devices Technology Insights


The heart failure POC & LOC devices market segmentation, based on technology, includes Microfluidics and Array-based Systems. The microfluidics category generated the most income as they are frequently employed to improve the operational protocols carried out in central laboratories. Additionally, it provides some advantages, like quicker turnaround times for results and less time spent on sample testing, which is expected to accelerate the segment's growth further. However, due to the increasing development of cutting-edge system techniques, the array-based systems segment is anticipated to grow at a sizable CAGR during the forecast period.


Figure 1: Heart Failure POC & LOC Devices Market, by Technology, 2022 & 2032 (USD billion) 


Heart Failure POC & LOC Devices Market, by Technology, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Heart Failure POC & LOC Devices End User Insights


The heart failure POC & LOC devices market segmentation, based on end user, includes Hospitals & Clinics, Homecare, Specialty Centers and Others. The store-based distribution channel category generated the most income because POC devices are distributed widely by hospitals and clinics for quick treatment. Such facilities can guide decision-makers toward the most effective end-user setting for managing heart failure problems.


Heart Failure POC & LOC Devices Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American heart failure POC & LOC devices market area will dominate this market since it generates a sizable organic revenue share as a result of significant competitor involvement. The market expansion in the region is primarily driven by early acceptance of cutting-edge medical technology and increased development of new technologies from important regional companies for the development of heart failure treatment devices.


Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: HEART FAILURE POC & LOC DEVICES MARKET SHARE BY REGION 2022 (%) 


HEART FAILURE POC & LOC DEVICES MARKET SHARE BY REGION 2022


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe heart failure POC & LOC devices market accounts for the second-largest market share as a result of factors including increased cardiovascular disease prevalence, a sophisticated and well-equipped healthcare infrastructure, the existence of major players, and rising microfluidics technology adoption. Further, the German heart failure POC & LOC devices market held the largest market share, and the UK heart failure POC & LOC devices market was the fastest growing market in the European region


The Asia-Pacific Heart failure POC & LOC devices Market is expected to grow at the fastest CAGR from 2023 to 2032 due to the region's modern infrastructure development and growing medical practice standards. Additionally, the regional market has grown as a result of major players shifting their investments from infectious to chronic diseases like cardiac ischemia, myocardial infarction, and acute coronary syndrome. Moreover, China’s heart failure POC & LOC devices market held the largest market share, and the Indian heart failure POC & LOC devices market was the fastest growing market in the Asia-Pacific region.


Heart failure POC & LOC devices Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the heart failure POC & LOC devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, heart failure POC & LOC devices industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the heart failure POC & LOC devices industry to benefit clients and increase the market sector. In recent years, the heart failure POC & LOC devices industry has offered some of the most significant advantages to medicine. Major players in the heart failure POC & LOC devices market attempting to increase market demand by investing in research and development operations include Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher (US), Abaxis, Inc. (US), Quidel Corporation (US), Siemens Healthineers (Germany), JantPharmacal Corporation (US), Trinity Biotech (Ireland), bioMérieux S.A (France), and Instrumentation Laboratory Company (US).


A division of Siemens AG, Siemens Healthineers AG (Siemens Healthineers) is a manufacturer and distributor of diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive treatments. The company's key products include mobile C-arms, hybrid operating rooms, angiography systems, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, and point-of-care (POC) testing systems. In April 2021, the AtellicaVTLi Patient-Side Immunoassay Analyzer from Siemens Healthineers has acquired CE mark clearance and can be used as a point-of-care diagnostic to help diagnose heart attacks.


Abaxis Inc. (Abaxis) is a provider of technology, tools, and services for a variety of medical applications for the care of patients in both human and veterinary settings. The company's primary areas of interest include developing, producing, and marketing portable blood analysis systems. Its portfolio includes patented goods like chemistry analyzers, reagent discs, blood gas and immunoassays, haematology analyzers and reagent rotors. Multiple tests are run on blood, serum, or plasma using the Abaxis laboratory system. The company distributes goods in the US through a network of independent distributors in the Asia, Americas, Europe, the Middle East, and Africa.


Key Companies in the heart failure POC & LOC devices market include




  • Abbott (US)




  • F. Hoffmann-La Roche Ltd. (Switzerland)




  • Danaher (US)




  • Abaxis, Inc. (US)




  • Quidel Corporation (US)




  • Siemens Healthineers (Germany)




  • JantPharmacal Corporation (US)




  • Trinity Biotech (Ireland)




  • bioMérieux S.A (France)




  • Instrumentation Laboratory Company (US)




Heart Failure POC & LOC Devices Industry Developments


October 2020:Butterfly Network Inc. introduced Butterfly iQ+ point-of-care ultrasound (POCUS), which turns a smartphone into an imaging device and aids in the point-of-care diagnosis of heart failure.


February 2019:The Saudi Arabian Ministry of Health (MOH) and ROYAL Philips worked together to provide an integrated Cardiovascular Information System (CVIS) nationwide. The CVIS would make all of the connected hospitals' medical records available to patients on demand. The goal of this effort was to enhance cardiac care.


Heart Failure POC & LOC Devices Market Segmentation


Heart Failure POC & LOC Devices Test Type Outlook




  • Proteomic Testing




  • Metabolomic Testing




  • Genomic Testing




Heart Failure POC & LOC Devices Technology Outlook



Heart Failure POC & LOC Devices End User Outlook




  • Hospitals & Clinics




  • Homecare




  • Specialty Centers




  • Others




Heart Failure POC & LOC Devices Regional Outlook




  • North America






  • US




  • Canada






  • Europe






  • Germany




  • France




  • UK




  • Italy




  • Spain




  • Rest of Europe






  • Asia-Pacific




    • China




    • Japan




    • India




    • Australia




    • South Korea




    • Australia




    • Rest of Asia-Pacific






  • Rest of the World




    • Middle East




    • Africa




    • Latin America





Report Scope:

Report Attribute/Metric Details
Market Size 2022 USD 0.05 billion
Market Size 2023 USD 0.0582 billion
Market Size 2032 USD 0.1976 billion
Compound Annual Growth Rate (CAGR) 16.50% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Distribution Channel, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher (US), Abaxis, Inc. (US), Quidel Corporation (US), Siemens Healthineers (Germany), JantPharmacal Corporation (US), Trinity Biotech (Ireland), bioMĂ©rieux S.A (France), and Instrumentation Laboratory Company (US)
Key Market Opportunities Increased funding for heart and cardiovascular disease research
Key Market Dynamics Increase in cardiovascular diseases Rise in geriatric population




Frequently Asked Questions (FAQ) :

The global heart failure POC & LOC devices market size was valued at USD 0.05 Billion in 2022.

The global market is projected to grow at a CAGR of 16.50% during the forecast period, 2023-2032.

The key players in the market are Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher (US), Abaxis, Inc. (US), Quidel Corporation (US), Siemens Healthineers (Germany), JantPharmacal Corporation (US), Trinity Biotech (Ireland), bioMĂ©rieux S.A (France), and Instrumentation Laboratory Company (US).

The proteomic testing category dominated the market in 2022.

The microfluidics category had the largest share in the global market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid